Characteristic | Laparoscopic group | Open surgery group (control) | P value |
---|---|---|---|
Sex (cases) | Â | Â | 0.904 |
 Men | 26 | 27 |  |
 Women | 5 | 6 |  |
Age (years) | Â | Â | 0.413 |
 Median | 54 | 59.5 |  |
 Range | 37–66 | 34–65 |  |
BMI | Â | Â | 0.912 |
 Median | 24.4 | 25.0 |  |
 Range | 19.1–31.0 | 21.8–29.9 |  |
Initial surgical lesion site (cases) | Â | Â | 0.665 |
 Right lobe | 22 | 25 |  |
 Left lobe | 9 | 8 |  |
Primary tumor size (cm) | 4.1 ± 1.5 | 4.9 ± 2.6 | 0.382 |
Time to recurrence (months) | 28.4 ± 27.7 | 27.5 ± 16.3 | 0.282 |
Size of recurrent tumor (cm) | 2.5 ± 1.0 | 3.8 ± 1.1 | 0.45 |
Recurrent site (cases) | Â | Â | 0.632 |
 Right lobe | 16 | 19 |  |
 Left lobe | 15 | 14 |  |
Operation method (cases) | Â | Â | 0.955 |
 Left lateral lobectomy | 12 | 13 |  |
 Local resection | 19 | 20 |  |
Total bilirubin (μmol/L) | 31.2 ± 7.4 | 33.7 ± 10.4 | 0.742 |
Albumin (g/L) | 35.2 ± 3.3 | 36.4 ± 4.3 | 0.532 |
ALT (U/L) | 49.6 ± 6.4 | 76.3 ± 7.5 | 0.671 |
AST (U/L) | 52.4 ± 7.4 | 69.4 ± 8.4 | 0.832 |
Prothrombin time (s) | 11.5 ± 0.7 | 12.4 ± 1.0 | 0.651 |
AFP (cases) | Â | Â | 0.264 |
 >400 ng/mL | 27 | 24 |  |
 <400 ng/mL | 4 | 9 |  |
HBV-DNA (log10 IU/mL) | 3.50 ± 0.8 | 3.0 ± 0.2 | 0.192 |